Does BioCryst Stock Offer Value After a 7% Weekly Surge and Rare Disease Optimism? [Yahoo! Finance]
BioCryst Pharmaceuticals, Inc. (BCRX)
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am
Check Earnings Report
US:NASDAQ Investor Relations:
biocryst.gcs-web.com/investor-relations
Company Research
Source: Yahoo! Finance
position, recent price swings are giving everyone something to talk about. Over just the past week, BioCryst's stock jumped by 7.0%, which might feel like a fresh breeze after a bumpier stretch: a 30-day dip of 8.1% and a year-to-date return of -8.2%. Zoom out, though, and there is still that long-term growth story, with the stock up a robust 92.8% over the last five years even after a deep pullback from its all-time highs. Much of the recent action ties back to growing optimism in the rare disease treatment market and ongoing positive sentiment around BioCryst's leading therapy, which continues to receive attention in both medical news and policy circles. Investors seem increasingly willing to look past earlier setbacks, recalibrating their view of the company's risk profile as new clinical collaborations and promising research updates make headlines. It is no wonder the valuation debate is heating up again. So, what is BioCryst's real value right now? Using a set of six criteria
Show less
Read more
Impact Snapshot
Event Time:
BCRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BCRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BCRX alerts
High impacting BioCryst Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
BCRX
News
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- BioCryst Pharmaceuticals (NASDAQ:BCRX) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- BioCryst Pharmaceuticals (BCRX): Valuation Check After Positive APeX-P Pediatric ORLADEYO Trial Update [Yahoo! Finance]Yahoo! Finance
- BioCryst Receives Early Termination of HSR Waiting Period for Astria AcquisitionGlobeNewswire
- BioCryst Data Highlights Severe Psychosocial Burden of HAE on Pediatric Patients, Caregivers [Yahoo! Finance]Yahoo! Finance
BCRX
Earnings
- 11/3/25 - Beat
BCRX
Sec Filings
- 12/3/25 - Form 4
- 12/3/25 - Form 144
- 12/3/25 - Form 8-K
- BCRX's page on the SEC website